Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 856 AL 870

Reversal of cognitive decline: a novel therapeutic program

Bredesen DE.

Aging (Albany NY). 2014 Sep;6(9):707-17. doi: 10.18632/aging.100690.

[Pharmacological and other options in preventing dementia: a literature review]

Csukly G, Sirály E, Hidasi Z, Salacz P, Szabó Á, Csibri É.

Neuropsychopharmacol Hung. 2014 Sep;16(3):121-6.

Angiotensin-converting enzyme insertion/deletion polymorphism is not a major determining factor in the development of sporadic Alzheimer disease: evidence from an updated meta-analysis

Wang XB, Cui NH, Yang J, Qiu XP, Gao JJ, Yang N, Zheng F.

PLoS One. 2014 Oct 31;9(10):e111406. doi: 10.1371/journal.pone.0111406. eCollection 2014.

Cardiovascular risk factors and future risk of Alzheimer's disease

de Bruijn RF, Ikram MA.

BMC Med. 2014 Nov 11;12:130. doi: 10.1186/s12916-014-0130-5.

Treatment of vascular risk factors in patients with a diagnosis of Alzheimer's disease: a systematic review

Valenti R, Pantoni L, Markus HS.

BMC Med. 2014 Nov 11;12:160. doi: 10.1186/s12916-014-0160-z.

Vascular risk factors and Alzheimer's disease

O'Brien JT, Markus HS.

BMC Med. 2014 Nov 11;12:218. doi: 10.1186/s12916-014-0218-y.

Meta-analysis of Ubiquilin1 gene polymorphism and Alzheimer's disease risk

Zhang T, Jia Y.

Med Sci Monit. 2014 Nov 12;20:2250-5. doi: 10.12659/MSM.891030.

Initial and long-term evaluation of patients with Alzheimer's after hospitalization in cognitive and behavioural units: the EVITAL study design

Pongan E, Freulon M, Delphin-Combe F, Dibie-Racoupeau F, Martin-Gaujard G, Federico D, Waissi A, Richard G, Jacqueline S, Fabre F, Trombert-Paviot B, Krolak-Salmon P, Laurent B, Rouch I.

BMC Psychiatry. 2014 Nov 15;14:308. doi: 10.1186/s12888-014-0308-6.

Alzheimer's preventive approaches and cognitive monitoring must be integrated into the primary care setting

Vellas B, Oustric S.

J Am Med Dir Assoc. 2014;15(11):783-5. doi: 10.1016/j.jamda.2014.09.005.

[Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer's disease?]

García-Casares N, García-Arnés JA, Gómez-Huelgas R, Valdivielso-Felices P, García-Arias C, González-Santos P.

Rev Neurol. 2014 Dec 1;59(11):517-24.

The role of nutrient-based epigenetic changes in buffering against stress, aging, and Alzheimer's disease

Chiu S, Woodbury-Fariña MA, Shad MU, Husni M, Copen J, Bureau Y, Cernovsky Z, Hou JJ, Raheb H, Terpstra K, Sanchez V, Hategan A, Kaushal M, Campbell R.

Psychiatr Clin North Am. 2014 Dec;37(4):591-623. doi: 10.1016/j.psc.2014.09.001. Epub 2014 Nov 25.

Right anterior insula: core region of hallucinations in cognitive neurodegenerative diseases

Blanc F, Noblet V, Philippi N, Cretin B, Foucher J, Armspach JP, Rousseau F; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2014 Dec 5;9(12):e114774. doi: 10.1371/journal.pone.0114774. eCollection 2014.

Anosognosia in Alzheimer's disease: diagnosis, frequency, mechanism and clinical correlates

Starkstein SE.

Cortex. 2014 Dec;61:64-73. doi: 10.1016/j.cortex.2014.07.019.

Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services

Wattmo C, Londos E, Minthon L.

Clin Interv Aging. 2014 Nov 14;9:1951-62. doi: 10.2147/CIA.S71709. eCollection 2014.

Predictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [Corrected]

Ma Y, Zhang S, Li J, Zheng DM, Guo Y, Feng J, Ren WD.

Medicine (Baltimore). 2014 Dec;93(27):e150. doi: 10.1097/MD.0000000000000150.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias